sparsentan will decrease the level or outcome of modafinil by impacting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor. Sparsentan (a CYP2C19 inducer) decreases publicity of CYP2C19 substrates and minimizes efficacy relevant to these substrates. tecovirimat will enhance the level or result of modafinil by influencing hepatic enzyme CYP2C19 metabolism. Use https://modafinil43209.blogunok.com/26331070/an-unbiased-view-of-modafinil